Integra LifeSciences Holdings Corporation, a regenerative tissue technologies and neurosurgical solutions provider, announced the appointment of Harvinder Singh as executive vice president and president of Integra’s international business.
Singh brings a wealth of global healthcare experience, specifically in the medical technology and pharmaceutical industries. Prior to joining Integra, Singh was at Abbott Laboratories for more than 20 years. Most recently, he served as a corporate officer and vice president of global commercial operations for the vascular business. During his tenure, Singh held several other senior leadership roles, including divisional vice president for Abbott Vascular in Asia Pacific.
Before joining Abbott, he worked for Guidant Corporation and Eli Lilly in sales, marketing, strategy and general management roles. Singh served as a member on the board of APACMed, the industry association of medical device companies in the Asia-Pacific region. He was also a board member of the American Medical Devices and Diagnostics Manufacturers’ Association in Japan.
“Harvinder is a proven leader who has demonstrated exemplary management capabilities internationally and a track record of accomplishments in the global healthcare industry,” said Jan De Witte, Integra LifeSciences president and CEO. “I look forward to Harvinder’s contributions to further expand our international business in line with our aspirational growth strategy.”
Singh graduated with a bachelor’s degree in chemistry and biology from Punjab University and received his master’s degree in business administration from the University of Indore, India. He is an alumnus of the Harvard Business School’s Advanced Management Program.
